Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.75 - $2.24 $375 - $1,120
500 New
500 $0
Q3 2021

Nov 05, 2021

SELL
$6.67 - $9.8 $5,969 - $8,771
-895 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$5.06 - $10.78 $4,528 - $9,648
895 New
895 $7,000
Q1 2021

May 24, 2021

SELL
$5.64 - $23.33 $11,533 - $47,709
-2,045 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$3.5 - $7.98 $245 - $558
-70 Reduced 3.31%
2,045 $12,000
Q3 2020

Nov 16, 2020

BUY
$4.78 - $16.97 $10,109 - $35,891
2,115 New
2,115 $14,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $53.1M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.